• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FUT2 通过 YAP/TAZ 信号和 SREBP-1 重编程脂肪酸代谢促进结直肠癌转移。

FUT2 promotes colorectal cancer metastasis by reprogramming fatty acid metabolism via YAP/TAZ signaling and SREBP-1.

机构信息

Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.

Institute of Glycobiological Engineering, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.

出版信息

Commun Biol. 2024 Oct 10;7(1):1297. doi: 10.1038/s42003-024-06993-x.

DOI:10.1038/s42003-024-06993-x
PMID:39390072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11467212/
Abstract

Colorectal cancer (CRC) ranks as the second most lethal cancer worldwide because of its high rate of metastasis, and approximately 20% of CRC patients have metastases at initial diagnosis. Metabolic reprogramming, a hallmark of cancer cells, has been implicated in the process of metastasis. We previously demonstrated that fucosyltransferase 2 (FUT2) promotes the malignancy of CRC cells, however, the underlying mechanisms remain unclear. Here, bioinformatic analysis revealed that FUT2 is associated with the malignant phenotype and fatty acid metabolism in CRC. FUT2 knockdown decreased glucose uptake and de novo fatty acid synthesis, which in turn inhibited the proliferation and metastasis of CRC cells. Mechanistically, FUT2 promotes YAP1 nuclear translocation and stabilizes mSREBP-1 by fucosylation, thus promoting de novo fatty acid synthesis in CRC cells. In summary, this study demonstrates that FUT2 promotes the proliferation and metastasis of CRC cells by reprogramming fatty acid metabolism via YAP/TAZ signaling and SREBP-1, indicating that FUT2 might be a potential target for developing therapeutic strategies against CRC.

摘要

结直肠癌(CRC)因其高转移率而成为全球第二大最致命的癌症,约 20%的 CRC 患者在初始诊断时就已经发生转移。代谢重编程是癌细胞的一个标志,与转移过程有关。我们之前的研究表明,岩藻糖基转移酶 2(FUT2)促进 CRC 细胞的恶性表型,然而,其潜在机制尚不清楚。在这里,生物信息学分析表明 FUT2 与 CRC 中的恶性表型和脂肪酸代谢有关。FUT2 的敲低降低了葡萄糖摄取和从头脂肪酸合成,进而抑制了 CRC 细胞的增殖和转移。在机制上,FUT2 通过岩藻糖基化促进 YAP1 的核易位和 mSREBP-1 的稳定,从而促进 CRC 细胞中的从头脂肪酸合成。综上所述,这项研究表明,FUT2 通过 YAP/TAZ 信号和 SREBP-1 重编程脂肪酸代谢促进 CRC 细胞的增殖和转移,表明 FUT2 可能是开发针对 CRC 的治疗策略的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4d8/11467212/8a9ec4d12b77/42003_2024_6993_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4d8/11467212/b0b5f3930fcd/42003_2024_6993_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4d8/11467212/1ef867f59f8c/42003_2024_6993_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4d8/11467212/a3d94dc848e8/42003_2024_6993_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4d8/11467212/29beba880d0a/42003_2024_6993_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4d8/11467212/e01501690ec1/42003_2024_6993_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4d8/11467212/a93944d7e484/42003_2024_6993_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4d8/11467212/ad7d26402acc/42003_2024_6993_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4d8/11467212/8a9ec4d12b77/42003_2024_6993_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4d8/11467212/b0b5f3930fcd/42003_2024_6993_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4d8/11467212/1ef867f59f8c/42003_2024_6993_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4d8/11467212/a3d94dc848e8/42003_2024_6993_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4d8/11467212/29beba880d0a/42003_2024_6993_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4d8/11467212/e01501690ec1/42003_2024_6993_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4d8/11467212/a93944d7e484/42003_2024_6993_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4d8/11467212/ad7d26402acc/42003_2024_6993_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4d8/11467212/8a9ec4d12b77/42003_2024_6993_Fig8_HTML.jpg

相似文献

1
FUT2 promotes colorectal cancer metastasis by reprogramming fatty acid metabolism via YAP/TAZ signaling and SREBP-1.FUT2 通过 YAP/TAZ 信号和 SREBP-1 重编程脂肪酸代谢促进结直肠癌转移。
Commun Biol. 2024 Oct 10;7(1):1297. doi: 10.1038/s42003-024-06993-x.
2
TIAM1 Antagonizes TAZ/YAP Both in the Destruction Complex in the Cytoplasm and in the Nucleus to Inhibit Invasion of Intestinal Epithelial Cells.TIAM1在细胞质中的破坏复合体以及细胞核中均拮抗TAZ/YAP,以抑制肠上皮细胞的侵袭。
Cancer Cell. 2017 May 8;31(5):621-634.e6. doi: 10.1016/j.ccell.2017.03.007. Epub 2017 Apr 13.
3
YAP/TAZ enhances P-body formation to promote tumorigenesis.YAP/TAZ增强P小体形成以促进肿瘤发生。
Elife. 2024 Jul 24;12:RP88573. doi: 10.7554/eLife.88573.
4
YAP/TAZ-TEAD activity promotes the malignant transformation of cervical intraepithelial neoplasia through enhancing the characteristics and Warburg effect of cancer stem cells.YAP/TAZ-TEAD 活性通过增强癌症干细胞的特性和瓦博格效应促进宫颈上皮内瘤变的恶性转化。
Apoptosis. 2024 Aug;29(7-8):1198-1210. doi: 10.1007/s10495-023-01935-0. Epub 2024 Mar 29.
5
RANBP1 promotes colorectal cancer progression by regulating pre-miRNA nuclear export via a positive feedback loop with YAP.RANBP1 通过与 YAP 形成正反馈环路调控前体 miRNA 的核输出促进结直肠癌的进展。
Oncogene. 2022 Feb;41(7):930-942. doi: 10.1038/s41388-021-02036-5. Epub 2021 Oct 6.
6
2-Hydroxylation of Fatty Acids Represses Colorectal Tumorigenesis and Metastasis via the YAP Transcriptional Axis.脂肪酸的 2-羟化作用通过 YAP 转录轴抑制结直肠肿瘤发生和转移。
Cancer Res. 2021 Jan 15;81(2):289-302. doi: 10.1158/0008-5472.CAN-20-1517. Epub 2020 Nov 17.
7
DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis.DNMT3A与YAP/TAZ协同作用促进胆囊癌转移。
Adv Sci (Weinh). 2024 Apr;11(16):e2308531. doi: 10.1002/advs.202308531. Epub 2024 Feb 21.
8
FUT2 promotes the tumorigenicity and metastasis of colorectal cancer cells via the Wnt/β‑catenin pathway.FUT2 通过 Wnt/β-连环蛋白通路促进结直肠癌细胞的致瘤性和转移。
Int J Oncol. 2023 Mar;62(3). doi: 10.3892/ijo.2023.5483. Epub 2023 Feb 3.
9
FUT2 inhibits the EMT and metastasis of colorectal cancer by increasing LRP1 fucosylation.FUT2 通过增加 LRP1 的岩藻糖基化来抑制结直肠癌的 EMT 和转移。
Cell Commun Signal. 2023 Mar 27;21(1):63. doi: 10.1186/s12964-023-01060-0.
10
Intestinal epithelium-specific Fut2 deficiency promotes colorectal cancer through down-regulating fucosylation of MCAM.肠上皮细胞特异性 Fut2 缺乏通过下调 MCAM 的岩藻糖基化促进结直肠癌。
J Transl Med. 2023 Feb 4;21(1):82. doi: 10.1186/s12967-023-03906-0.

引用本文的文献

1
Glucose Metabolic Reprogramming in Colorectal Cancer: From Mechanisms to Targeted Therapy Approaches.结直肠癌中的葡萄糖代谢重编程:从机制到靶向治疗方法
Cancer Med. 2025 Sep;14(17):e71185. doi: 10.1002/cam4.71185.
2
Replication of the GWAS-Identified GALNT13 rs10196189 Polymorphism in Relation to Speed-Power Elite Active Athlete Status and Multidimensional Phenotypic Differences in Chinese Han Males: A Pilot Study.全基因组关联研究确定的GALNT13基因rs10196189多态性与速度力量型优秀现役运动员状态及中国汉族男性多维表型差异的相关性:一项初步研究
Genes (Basel). 2025 Aug 20;16(8):983. doi: 10.3390/genes16080983.
3
Liquid-liquid phase separation of GPS2-LATS1 promotes colorectal cancer progression by reprogramming lipid metabolism.

本文引用的文献

1
The mA modification mediated-lncRNA POU6F2-AS1 reprograms fatty acid metabolism and facilitates the growth of colorectal cancer via upregulation of FASN.mA 修饰介导长链非编码 RNA POU6F2-AS1 通过上调 FASN 重编程脂肪酸代谢并促进结直肠癌细胞的生长。
Mol Cancer. 2024 Mar 16;23(1):55. doi: 10.1186/s12943-024-01962-8.
2
Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation.铁死亡:癌症与炎症中新兴的机制、生物学功能及治疗潜力
Cell Death Discov. 2024 Jan 24;10(1):45. doi: 10.1038/s41420-024-01825-7.
3
GALNT12 promotes fibrosarcoma growth by accelerating YAP1 nuclear localization.
GPS2-LATS1的液-液相分离通过重编程脂质代谢促进结直肠癌进展。
Oncogene. 2025 Jul 25. doi: 10.1038/s41388-025-03498-7.
4
Integrated muti-omics data and machine learning reveal CD151 as a key biomarker inducing chemoresistance in metabolic syndrome-related early-onset left-sided colorectal cancer.整合多组学数据和机器学习揭示CD151是代谢综合征相关早发性左侧结直肠癌中诱导化疗耐药的关键生物标志物。
Funct Integr Genomics. 2025 Jun 9;25(1):122. doi: 10.1007/s10142-025-01634-w.
5
Focusing on DC cells to optimize the prediction of prognosis and innovative treatment strategies for colon cancer.聚焦于树突状细胞以优化结肠癌预后预测及创新治疗策略。
Sci Rep. 2025 May 19;15(1):17298. doi: 10.1038/s41598-025-01792-8.
6
The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma.肾细胞癌中代谢重编程的发病机制及治疗意义
Cell Death Discov. 2025 Apr 19;11(1):186. doi: 10.1038/s41420-025-02479-9.
7
The Role of Cholesterol Metabolism and Its Regulation in Tumor Development.胆固醇代谢及其调节在肿瘤发生中的作用。
Cancer Med. 2025 Apr;14(7):e70783. doi: 10.1002/cam4.70783.
8
Association between quantitative CT body composition analysis and prognosis in cetuximab-based first-line treatment for advanced colorectal cancer patients.定量CT体成分分析与晚期结直肠癌患者基于西妥昔单抗的一线治疗预后之间的关联
BMC Cancer. 2024 Dec 26;24(1):1579. doi: 10.1186/s12885-024-13338-8.
GALNT12通过加速YAP1核定位促进纤维肉瘤生长。
Oncol Lett. 2023 Nov 3;26(6):543. doi: 10.3892/ol.2023.14131. eCollection 2023 Dec.
4
Glucose-induced and ChREBP: MLX-mediated lipogenic program promotes hepatocellular carcinoma development.葡萄糖诱导的以及ChREBP:MLX介导的脂肪生成程序促进肝细胞癌的发展。
Oncogene. 2023 Oct;42(43):3182-3193. doi: 10.1038/s41388-023-02831-2. Epub 2023 Sep 9.
5
Colorectal cancer statistics, 2023.2023 年结直肠癌统计数据。
CA Cancer J Clin. 2023 May-Jun;73(3):233-254. doi: 10.3322/caac.21772. Epub 2023 Mar 1.
6
Intestinal epithelium-specific Fut2 deficiency promotes colorectal cancer through down-regulating fucosylation of MCAM.肠上皮细胞特异性 Fut2 缺乏通过下调 MCAM 的岩藻糖基化促进结直肠癌。
J Transl Med. 2023 Feb 4;21(1):82. doi: 10.1186/s12967-023-03906-0.
7
FUT2 promotes the tumorigenicity and metastasis of colorectal cancer cells via the Wnt/β‑catenin pathway.FUT2 通过 Wnt/β-连环蛋白通路促进结直肠癌细胞的致瘤性和转移。
Int J Oncol. 2023 Mar;62(3). doi: 10.3892/ijo.2023.5483. Epub 2023 Feb 3.
8
Metabolism and Colorectal Cancer.代谢与结直肠癌
Annu Rev Pathol. 2023 Jan 24;18:467-492. doi: 10.1146/annurev-pathmechdis-031521-041113. Epub 2022 Nov 2.
9
Therapeutic potential of fucosyltransferases in cancer and recent development of targeted inhibitors.岩藻糖基转移酶在癌症治疗中的潜力及靶向抑制剂的最新进展。
Drug Discov Today. 2023 Jan;28(1):103394. doi: 10.1016/j.drudis.2022.103394. Epub 2022 Oct 9.
10
PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.蛋白酪氨酸磷酸酶受体型O通过重编程脂肪酸代谢来抑制结直肠癌的肿瘤发生和进展。
Cancer Commun (Lond). 2022 Sep;42(9):848-867. doi: 10.1002/cac2.12341. Epub 2022 Jul 29.